A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration

Gynecologic Oncology

Volumn 106, Issue 1, 2007, Pages 177-180

  Husain, Amreen ^a   Akhurst, Timothy ^a   Larson, Steven ^a   Alektiar, Khaled ^a   Barakat, Richard R ^a   Chi, Dennis S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Pelvic exenteration; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS EXENTERATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; VAGINA CANCER;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; GENITAL NEOPLASMS, FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 34250191463     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.03.018     Document Type: Article

References (15)

1. Rubin SC, Hoskins WJ. Cervical cancer and preinvasive neoplasia (ed): Lippincott-Raven Publishers, Philadelphia. 1996.
2. Stehman F.B., Perez C.A., and Kurman R.J. Uterine cervix. Principles and practice of gynecologic oncology. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia
3. Ascher S.M., Brown J.J., and Walsh J.W. Diagnostic imaging techniques in gynecologic oncology. Principles and Practice of Gynecologic Oncology. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia
4. Warburg O. The Metabolism of Tumours (1931), Richard R. Smith, Inc., New York
5. Hoh C.K., Schiepers C., Seltzer M.A., et al. PET in oncology: will it replace the other modalities?. Sem. Nuc. Med. 27 (1997) 94-106
6. Larson S.M. Positron emission tomography in oncology and allied diseases. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer, Principles and Practice of Oncology. 2nd ed. vol. 3 (2) (1989), JB Lippincott Publishing, Philadelphia 1-12
7. DeGrado T.R., et al. Performance characteristics of a whole-body PET scanner. J. Nucl. Med. 35 8 (1994) 1398-1406
8. Grisby P.W., Siegel B.A., and Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J. Clin. Oncol. 19 (2001) 3745-3749
9. 18F-FDG PET for detection of paraaortic lymph node metastasis in cervical cancer patients. J. Nucl. Med. 44 (2003) 1775-1783
10. Singh A.K., Grisgby P.W., Dahdashti F., et al. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56 2 (2003) 489-493
11. Unger J., Ivy J., Connor P., et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol. Oncol. 94 (2004) 212-216
12. Grigsby B., Dehdashti F., et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J. Clin. Oncol. 22 (2004) 2167-2171
13. Yen T.C., Ma S.Y., et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J. Clin. Oncol. 21 (2003) 3651-3658
14. Lai C., Huang K., See L., et al. Restaging of recurrent cervical carcinoma with dual-phase [18F] fluoro-2-deoxy-d-glucose positron emission tomography. Cancer 100 (2004) 544-552
15. Havrilesky L.J., Wong T.Z., Secord A.A., et al. The role of PET scanning in the detection of recurrent cervical cancer. Gynecol. Oncol. 90 1 (2003 (Jul.)) 186-190